- Roche KRAS drug succeeds in head-to-head lung cancer study<figure><div><img src="https://imgproxy.divecdn.com/Sx5xDgNmDFUjqj0qcGVTS7IkwSLxPHMSmgzypS8Uexg/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xOTM3MjY1MDU5XzEua…BioPharma Dive · 24d ago↗ source
- STAT+: Roche drug sets new standard for KRAS-driven lung cancerBiotech's bull market, Vertex's gene therapy expansion, and more news from The ReadoutSTAT · 24d ago↗ source
- Vertex's sickle cell therapy approved for kids; United Therapeutics buys startup🧬 Vertex’s sickle cell gene therapy approved for kids: Casgevy may now be used to treat either sickle cell disease with recurrent vaso-occlusive crises or transfusion-dependent β-thalassemia patie…Endpoints